The results showed that all prognostic CRGs were elevated in advanced LUAD samples as well as in LUAD samples with brain metastases; in particular, EGFR was more expressed in samples with brain metastases, while PTGES3 was significantly elevated in all tumor samples used (Figure 2C). Here, PTGES3 is linked to neoplasm.